CoChat

Senescence Sensitivity of Breast Cancer Cells Is Defined by Positive Feedback Loop between CIP2A and E2F1

Open access
Laine, Anni, Sihto, Harri, Come, Christophe, Rosenfeldt, Mathias T., Zwolinska, Aleksandra, Niemelä, Minna, Khanna, Anchit, Chan, Edward K., Kähäri, Veli-Matti, Kellokumpu-Lehtinen, Pirkko-Liisa, Sansom, Owen J., Evan, Gerard I., Junttila, Melissa R., Ryan, Kevin M., Marine, Jean-Christophe, Joensuu, Heikki, Westermarck, Jukka · 2013 · Cancer Discovery

Published version of a preprint

The DOI matches its Crossref record; 60 of the 62 references it cites were found in a registry or an index.

Abstract

Senescence induction contributes to cancer therapy responses and is crucial for p53-mediated tumor suppression. However, whether p53 inactivation actively suppresses senescence induction has been unclear. Here, we show that E2F1 overexpression, due to p53 or p21 inactivation, promotes expression of human oncoprotein CIP2A, which in turn, by inhibiting PP2A activity, increases stabilizing serine 364 phosphorylation of E2F1. Several lines of evidence show that increased activity of E2F1-CIP2A feedback renders breast cancer cells resistant to senescence induction. Importantly, mammary tumorigenesis is impaired in a CIP2A-deficient mouse model, and CIP2A-deficient tumors display markers of senescence induction. Moreover, high CIP2A expression predicts for poor prognosis in a subgroup of patients with breast cancer treated with senescence-inducing chemotherapy. Together, these results implicate the E2F1-CIP2A feedback loop as a key determinant of breast cancer cell sensitivity to senescence induction. This feedback loop also constitutes a promising prosenescence target for therapy of cancers with an inactivated p53–p21 pathway. Significance: It has been recently realized that most currently used chemotherapies exert their therapeutic effect at least partly by induction of terminal cell arrest, senescence. However, the mechanisms by which cell-intrinsic senescence sensitivity is determined are poorly understood. Results of this study identify the E2F1-CIP2A positive feedback loop as a key determinant of breast cancer cell sensitivity to senescence and growth arrest induction. Our data also indicate that this newly characterized interplay between 2 frequently overexpressed oncoproteins constitutes a promising prosenescence target for therapy of cancers with inactivated p53 and p21. Finally, these results may also facilitate novel stratification strategies for selection of patients to receive senescence-inducing cancer therapies. Cancer Discov; 3(2); 182–97. ©2013 AACR. This article is highlighted in the In This Issue feature, p. 125

Overview

Integrity signals

Registry

Crossref · 10.1158/2159-8290.cd-12-0292

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

4 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 60 references

Cited by

See all 151

Metadata

Authors
Laine, A., Sihto, H., Come, C., Rosenfeldt, M. T., Zwolinska, A., Niemelä, M., Khanna, A., Chan, E. K., Kähäri, V.-M., Kellokumpu-Lehtinen, P.-L., Sansom, O. J., Evan, G. I., Junttila, M. R., Ryan, K. M., Marine, J.-C., Joensuu, H., & Westermarck, J.
Affiliations
  • Åbo Akademi University (FI)
  • Authors' Affiliations: 1Turku Centre for Biotechnology, University of Turku and Åbo Akademi University, and 2Turku Doctoral Program of Biomedical Sciences, University of Turku; Departments of 3Pathology, 4Medical Biochemistry and Genetics, and 5Dermatology, University of Turku and Turku University Hospital, MediCity Research Laboratory, University of Turku, Turku, 6Laboratory of Molecular Oncology, Molecular Cancer Biology Program, Biomedicum, and 7Department of Oncology, Helsinki University Central Hospital, University of Helsinki, Helsinki; 8Institute of Biomedical Technology and 9Department of Oncology, University of Tampere and Tampere University Hospital, Tampere, Finland; 10The Beatson Institute for Cancer Research, Glasgow, United Kingdom; 11Laboratory for Molecular Cancer Biology, Center for Human Genetics and VIB11—Center for the Biology of Disease, VIB-KULeuven, Leuven, Belgium; 12Department of Oral Biology, University of Florida, Gainesville, Florida; and 13Department of Pathology and Helen Diller
Corresponding author
Westermarck, Jukka
Venue
Cancer Discovery
Published
2013-02-01
Volume
3
Issue
2
Pages
182-197
ISSN
  • 2159-8274 (ISSN-L)
  • 2159-8290
OpenAlex
W2099186537
Cited by
130
References
62
Citations by year
2026: 4 · 2025: 6 · 2024: 2 · 2023: 15 · 2022: 7 · 2021: 12 · 2020: 10 · 2019: 8 · 2018: 13 · 2017: 10 · 2016: 7 · 2015: 17 · 2014: 9 · 2013: 10
FWCI
9.95
Type
journal article
Language
en
Open access
Locations
  • Cancer Discovery (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
Funders
Cancer Research UK (A10419, 12481, 15816)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
Keywords
cellular senescence, breast cancer, CIP2A, E2F1, positive feedback loop, p53 inactivation, p21, protein phosphatase 2A, senescence resistance, mammary carcinogenesis, prognostic factors
MeSH terms
Docetaxel, Vinorelbine, Animals, Antinematodal Agents, Autoantigens, Breast Neoplasms, Embryo, Mammalian, Female, Fibroblasts, Humans, Membrane Proteins, Vinblastine, Blotting, Western, Mammary Neoplasms, Animal, Tumor Suppressor Protein p53, Cellular Senescence, Mice, Knockout, Drug Resistance, Neoplasm, Reverse Transcriptase Polymerase Chain Reaction, Feedback, Physiological, Taxoids, HCT116 Cells, Cell Line, Tumor, Intracellular Signaling Peptides and Proteins, Cell Proliferation, E2F1 Transcription Factor, Cyclin-Dependent Kinase Inhibitor p21, Mice, MCF-7 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Senescence Sensitivity of Breast Cancer Cells Is Defined by Positive Feedback Loop between CIP2A and E2F1. https://app.cochat.ai/papers/10.1158/2159-8290.cd-12-0292
The paper
Laine, A., Sihto, H., Come, C., Rosenfeldt, M. T., Zwolinska, A., Niemelä, M., Khanna, A., Chan, E. K., Kähäri, V.-M., Kellokumpu-Lehtinen, P.-L., Sansom, O. J., Evan, G. I., Junttila, M. R., Ryan, K. M., Marine, J.-C., Joensuu, H., & Westermarck, J. (2013). Senescence Sensitivity of Breast Cancer Cells Is Defined by Positive Feedback Loop between CIP2A and E2F1. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-12-0292

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.